Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT00113802
Eligibility Criteria:
Inclusion Criteria:
* Documented diagnosis of Waldenström's Macroglobulinemia using criteria proposed at 2nd International Workshop on WM, Athens, Greece, 2002.
* Measurable disease, defined as serum monoclonal IgM protein ≥1000 mg/dL by electrophoresis.
* Lymphoplasmacytic infiltration of the bone marrow \>10% involvement.
* Failed at least one, but no more than 3, regimen(s) of prior therapy.
(Please consult with study site for full eligibility criteria)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00113802
Study Brief:
Protocol Section:
NCT00113802